期刊文献+

盐酸恩丹西酮乳酸羟基乙酸共聚物微球中药物的含量测定 被引量:4

Determination the Drug Content of Ondansetron Hydrochloride-loaded Poly (lactide-co-glycolide) Micro-spheres by Ultraviolet Spectrophotometry
下载PDF
导出
摘要 目的:建立测定盐酸恩丹西酮乳酸羟基乙酸共聚物微球含量的方法。方法:采用二氯甲烷溶解微球后,再以水提取主药,用紫外分光光度法测定药物的含量。结果:盐酸恩丹西酮在2-20μg·ml-1的范围内,浓度与吸收度的线性关系良好, 平均回收率为98.76%±0.64%,RSD为1.82%。结论:该方法操作简单、可靠,可用于快速测定微球中药物的含量。 Objective: To establish a method to determine the drug content of Ondansetron Hydroehloride-loaded PLGA microspheres. Method: Water was used to abstract the drug after microspheres was dissolved completely in dichloromethane. Ultraviolet Spectrophotometry was applied to determine drug concentration. Result: The method showed a good linearity in the concentration range of 2 - 20 μg·ml^-1. The average recovery was 98.76 ± 0.64%, RSD was 1.82%. Conclusion: The method was simple, reliable and coule be used to detect the drug content of microspheres accurately and quickly.
出处 《中国药师》 CAS 2005年第12期1012-1014,共3页 China Pharmacist
关键词 盐酸恩丹西酮 微球 乳酸羟基乙酸共聚物 紫外分光光度法 Ondansetron Hydroehloride Mierospheres poly( laetide - -eo-glyeolide) Ultraviolet Speetrophotometry
  • 相关文献

参考文献3

  • 1Trainer MR, Reynolds DJM, Stoner NS,et al. Efficacy of 5 -HT3 Receptor Antagonists in radiotherapy-induced nausea and vomiting:a quantitative systematic review[J ]. European J Cancer, 1998,34( 12 ) : 1836-1844.
  • 2Machida Y,Onishi H,Kufita A,et al. Phatmacokinetics of prolonged -release CPT - 11 - loaded microspheres in rats [ J ]. y Control Release, 2000,66 ( 6 ) :159-175.
  • 3Blanco-Prieto M J, Besseghir K,Zerbe O,et al. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres[ J]. J Control Release,2000,67(7 ) : 19-28.

同被引文献25

  • 1周毅生,卢毅,宋华,翟冬燕,段琼辉.替硝唑胃内滞留漂浮型缓释片的制备及体外释放研究[J].广东药学院学报,2006,22(1):1-3. 被引量:5
  • 2李芳,李瑛,刘建平,颜圣.复方左炔诺孕酮片的体外溶出度比较[J].药学服务与研究,2006,6(6):417-420. 被引量:5
  • 3Kumar N, Koide S S, Tsong Y, etal. Nestorone: a progestin with a unique pharmacological profile [ J ]. Stero/ds, 2000,65 ( 10/11 ) :629-636.
  • 4Diaz S, Schiappacasse V ,Pavez M ,et al. Clinical trail with Nestorone subdermal contraceptive implants [ J ]. Contraception,1995,51 ( 1 ) :33-38.
  • 5Sivin I, Croxatto H, Bahamondes L,etal. Two-year performance of a Nestorone@-releasing contranceptive implant: a three-center study of 300 women [ J ]. Contraception,2004,69(2) :137-144.
  • 6孟凡静,刘桂琴,赵强,等.HPLC法测定家兔体内左炔诺孕酮的血药浓度[c]//中国化学会第十五次全国色谱学术报告会文集(下册).大连:中国化学会色谱专业委员会,2005:460-461.
  • 7MARTY M. Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting[J]. Eur J Cancer Clin Oncol,1989, 25(Suppl 1) : S41-S45.
  • 8DRAPER N R, LIN D K J, Small response-surface designs[J]. Technometrics, 1990, 32(2): 187-194.
  • 9NUTANMT H, SOLIMAN MS, TAHAEI, et al. Optimization and characterization of controlled release multi-particulate beads coated with starch acetate[J]. Int J Pharm,2005, 294(1-2): 89-101.
  • 10ELKHESHEN S A, RADWAN M A, Sustained release mierospheres of metoclopramide using poly(D, L-lactide co gly-colide) copolymers [J]. J Microeneapsul, 2000.17 (4) : 425-435.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部